CME Group Inc. (NASDAQ:CME) Sees Large Decline in Short Interest

CME Group Inc. (NASDAQ:CMEGet Rating) was the recipient of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 3,950,000 shares, a drop of 9.6% from the October 15th total of 4,370,000 shares. Based on an average daily volume of 1,640,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.1% of the company’s stock are short sold.

Analysts Set New Price Targets

A number of equities analysts recently commented on CME shares. Raymond James cut CME Group from an “outperform” rating to a “market perform” rating in a report on Monday, August 15th. UBS Group cut their price objective on shares of CME Group from $246.00 to $240.00 and set a “buy” rating for the company in a research report on Tuesday, August 2nd. Rosenblatt Securities cut their price objective on shares of CME Group from $171.00 to $161.00 and set a “sell” rating for the company in a research report on Wednesday, October 5th. Citigroup started coverage on shares of CME Group in a research report on Tuesday, October 11th. They set a “buy” rating and a $220.00 price objective for the company. Finally, StockNews.com started coverage on shares of CME Group in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $223.86.

Insider Buying and Selling at CME Group

In other news, Director William R. Shepard purchased 48,645 shares of the company’s stock in a transaction on Friday, November 4th. The shares were purchased at an average price of $170.00 per share, with a total value of $8,269,650.00. Following the purchase, the director now directly owns 247,843 shares of the company’s stock, valued at approximately $42,133,310. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, Director William R. Shepard acquired 48,645 shares of the firm’s stock in a transaction dated Friday, November 4th. The stock was bought at an average price of $170.00 per share, for a total transaction of $8,269,650.00. Following the acquisition, the director now directly owns 247,843 shares of the company’s stock, valued at $42,133,310. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Daniel R. Glickman sold 500 shares of the firm’s stock in a transaction dated Wednesday, August 31st. The shares were sold at an average price of $196.39, for a total value of $98,195.00. Following the completion of the transaction, the director now owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The disclosure for this sale can be found here. Insiders have sold 5,610 shares of company stock valued at $1,123,970 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

Several institutional investors and hedge funds have recently made changes to their positions in CME. Massachusetts Financial Services Co. MA grew its stake in CME Group by 132.0% during the first quarter. Massachusetts Financial Services Co. MA now owns 3,382,773 shares of the financial services provider’s stock worth $804,626,000 after purchasing an additional 1,924,772 shares during the period. Capital International Investors grew its stake in CME Group by 8.4% during the first quarter. Capital International Investors now owns 14,292,196 shares of the financial services provider’s stock worth $3,400,650,000 after purchasing an additional 1,104,075 shares during the period. TD Asset Management Inc. grew its stake in CME Group by 224.1% during the first quarter. TD Asset Management Inc. now owns 992,012 shares of the financial services provider’s stock worth $235,960,000 after purchasing an additional 685,884 shares during the period. Lord Abbett & CO. LLC acquired a new stake in CME Group during the first quarter worth approximately $145,971,000. Finally, Renaissance Technologies LLC grew its stake in CME Group by 208.9% during the second quarter. Renaissance Technologies LLC now owns 854,289 shares of the financial services provider’s stock worth $174,873,000 after purchasing an additional 577,700 shares during the period. Institutional investors and hedge funds own 85.56% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $173.53 on Friday. The firm’s fifty day moving average price is $177.56 and its two-hundred day moving average price is $193.22. The stock has a market cap of $62.42 billion, a PE ratio of 23.61, a PEG ratio of 2.82 and a beta of 0.41. CME Group has a fifty-two week low of $166.58 and a fifty-two week high of $256.94. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Rating) last issued its quarterly earnings data on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.05. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.23 billion. CME Group had a net margin of 54.01% and a return on equity of 10.06%. On average, equities analysts expect that CME Group will post 7.96 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Stockholders of record on Friday, December 9th will be paid a $1.00 dividend. The ex-dividend date is Thursday, December 8th. This represents a $4.00 annualized dividend and a dividend yield of 2.31%. CME Group’s payout ratio is 54.42%.

CME Group Company Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Featured Stories

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.